Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2013
06/20/2013WO2013089252A1 Modification of helper t cell-inducing polypeptide
06/20/2013WO2013088445A1 Pyrimidine derivatives for treatment of inflammatory diseases
06/20/2013WO2013088373A1 Amorphous vilazodone hydrochloride, a process for its preparation and pharmaceutical compositions thereof
06/20/2013WO2013088315A1 Sulfonamide derivatives
06/20/2013WO2013088255A1 Prodrugs of secondary amine compounds
06/20/2013WO2013088254A1 Transdermal delivery system comprising buprenorphine
06/20/2013WO2013088243A1 Compositions of buprenorphine and mu-opioid receptor antagonists
06/20/2013WO2013088242A1 Samidorphan (alks 33) in combination with opioid agonists
06/20/2013WO2013088111A1 Use of antibody
06/20/2013WO2013087954A1 Compounds that inhibit beta amyloid peptide aggregation
06/20/2013WO2013087943A1 P2x7 antagonists as frontline or adjunctive treatment against status epilepticus
06/20/2013WO2013087808A1 Pharmaceutical composition comprising a pyrazolopyrimidme and cyclodextrin
06/20/2013WO2013087807A1 4-aryl imidazole derivatives as mglu5 positive allesteric modiulators
06/20/2013WO2013087806A1 Piperazine derivatives and their use as positive allosteric modulators of mglu5 receptors
06/20/2013WO2013087805A1 Piperazine derivatives and their use as positive allosteric modulators of mglu5 receptors
06/20/2013WO2013087739A1 4-aryl imidazole derivatives as mglur5 positive allosteric modulators
06/20/2013WO2013087738A1 Novel compounds
06/20/2013WO2013087643A1 1,3,5 -triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof
06/20/2013WO2013087575A1 (11ss,17ss)-17-hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoro- ethyl)estra-4,9-dien-3-one for the treatment of charcot marie tooth disease
06/20/2013WO2013087563A1 Pharmaceutical composition comprising (s)-2-(2-oxopyrrolidin-1-yl)butanamid
06/20/2013WO2013087410A1 Treatment of migraine headaches, in particular cluster headaches
06/20/2013WO2013087042A1 Medical composition for preventing or treating amyloid β peptide related diseases or conditions
06/20/2013WO2013086574A1 Method of treatment
06/20/2013WO2013061279A4 Uses of indole-ketones or indolidones as neuro-protective drugs
06/20/2013WO2013058681A3 Substituted phenoxyacetic acids and esters and amides thereof, comprising a 2,6-dioxo-2,3,6,7-tetrahydro-1н-purine-8-yl fragment and constituting а2a adenosine receptor antagonists, and the use thereof
06/20/2013WO2013050529A3 Use of igf-1 in the stimulation of treg cell activity and the treatment autoimmune disorders
06/20/2013WO2013045380A3 Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification
06/20/2013US20130158129 Natural, multiple release and re-use compositions
06/20/2013US20130158077 Pharmaceutical compositions
06/20/2013US20130158064 Novel iso-ergoline derivatives
06/20/2013US20130158061 Controlled release hydrocodone
06/20/2013US20130157965 Prevention and Treatment of Oxidative Stress Disorders by Glutathione and Phase II Detoxification Enzymes
06/20/2013US20130157950 Method for treating and/or preventing neurodegenerative disease by adiponectin receptor agonist
06/20/2013US20130156751 Treatment of diseases
06/20/2013US20130156712 Stable surfactant compositions for suspending components
06/20/2013US20130156699 Radiolabeled compounds and uses thereof
06/20/2013CA2858531A1 Transdermal delivery system comprising buprenorphine
06/20/2013CA2858025A1 Chemical compound useful as intermediate for preparing a catechol-o-methyltransferase inhibitor
06/20/2013CA2857603A1 Sulfonamide derivatives
06/20/2013CA2857057A1 Fluorinated estrogen receptor modulators and uses thereof
06/19/2013EP2604611A1 N-Biaryl substituted diazabicycloalkane derivatives as agonists of the alpha7 and alpha4beta2 nACh Receptor
06/19/2013EP2604606A1 Inhibitor of casein kinase 1 and casein kinase 1
06/19/2013EP2604602A1 Heteroaryl-pyrazole derivative
06/19/2013EP2604597A1 Heterocyclic compound and use thereof
06/19/2013EP2604595A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity
06/19/2013EP2604265A1 P2x7 antagonists as frontline or adjunctive treatment against status epilepticus
06/19/2013EP2604257A1 Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms
06/19/2013EP2604109A1 Model mouse of attention deficit hyperactivity disorder, method for investigating effects for preventing and alleviating attention disorder using the model mouse, and method for treating attention disorder by suppressing t-type calcium channel
06/19/2013EP2603524A1 Amyloid-beta binding proteins
06/19/2013EP2603523A1 ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
06/19/2013EP2603513A1 Heterocyclic compound and use thereof
06/19/2013EP2603511A1 6-cycloalkyl-1, 5-dihydro-pyrazolo [3, 4-d]pyrimidin-4-one derivatives and their use as pde9a inhibitors
06/19/2013EP2603495A1 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms
06/19/2013EP2603493A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
06/19/2013EP2603492A1 Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof
06/19/2013EP2603490A1 Novel trpv3 modulators
06/19/2013EP2603487A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
06/19/2013EP2603481A2 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
06/19/2013EP2603224A1 Methods and compositions for preventing a condition
06/19/2013EP2603219A1 Combination of glyt1 compound with antipsychotics
06/19/2013EP2603217A1 Novel 6,7-disubstituted-isoquinoline derivatives and their use
06/19/2013EP2603212A1 Use of rasagiline for the treatment of olfactory dysfunction
06/19/2013CN103168042A 7-((1,2,3)Triazol-4-yl)-pyrrolo(2,3) pyrazinderivate
06/19/2013CN103168041A 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof
06/19/2013CN103168033A Quinazoline compounds as sodium channel blockers
06/19/2013CN103168028A Cyclic amide derivative
06/19/2013CN103160557A Purpose of ribosomal protein S5 in catalyzing of protein molecules for generatation of dephosphorylation reaction
06/19/2013CN103159844A Method capable of reducing immunotoxicity of venom nerve growth factor and enabling immunotoxicity to be drug alternative of mouse origin nerve growth factor
06/19/2013CN103159843A Preparation method and drug application value of nerve growth factor mutant with low immunization side effects
06/19/2013CN103159832A Peptide with neuroprotective effect, preparation method thereof, pharmaceutical composition and purpose
06/19/2013CN103159788A Condensed imidazole formamide serving as transient receptor potential vanillin 3 (TRPV3) modifier
06/19/2013CN103159760A Azaindole derivatives as cftr modulators
06/19/2013CN103159742A 5-Chloropyrimidine compound and application of 5-Chloropyrimidine compound serving as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor
06/19/2013CN103159738A Mixed aromatic compound of alkynyl bridging and application thereof
06/19/2013CN103159726A Chromene ketone derivative used as transient receptor potential vanillin3 (TRPV3) antagonist
06/19/2013CN103159636A Aminomethyl caproic acid derivative and use
06/19/2013CN103158747A Solar energy baby carriage
06/19/2013CN103157111A New combinaition and pharmaceutical compositions containing same
06/19/2013CN103157098A Research for coordinate regulation for microtubule cytoskeleton structure and microfilament cytoskeleton structure and promotion for muscular contraction of UNC-51 kinase
06/19/2013CN103157093A Drug for treating insomnia
06/19/2013CN103157092A Drug for treating schizophrenia
06/19/2013CN103157067A Traditional Chinese medicine preparation for treating trigeminal neuralgia
06/19/2013CN103157054A Chinese herba preparation for treating carbon monoxide poisoning delayed type encephalopathy
06/19/2013CN103157025A Qi tonifying and yang elevating pill
06/19/2013CN103157018A Solvent used for treating Parkinson's disease
06/19/2013CN103157017A Medicine used for treating Parkinsonism
06/19/2013CN103157016A Traditional Chinese medicine for treating vertigo with syndrome of retention of phlegm and dampness in middle energizer
06/19/2013CN103157007A Grassleaf sweelflag rhizome and hairyvein agrimony composition medicament
06/19/2013CN103156999A Medicament preparation for treating neurasthenia
06/19/2013CN103156975A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, and preparation method thereof
06/19/2013CN103156971A Medicine used for controlling senile dementia
06/19/2013CN103156967A Medicine liquid used for treating dementia
06/19/2013CN103156956A Blood replenishing oral liquid and preparation method thereof
06/19/2013CN103156948A Medicament for treating influenza
06/19/2013CN103156929A 脑瘫康丸 Cerebral palsy Pill
06/19/2013CN103156927A Traditional Chinese medicine for treating headache
06/19/2013CN103156923A Application of humulus lupulus effective parts applied to preparation of medicine for preventing and improving depression and clinical symptoms
06/19/2013CN103156918A Neurasthenia and sleeplessness treatment traditional Chinese medicine syrup and preparation method thereof
06/19/2013CN103156898A Compound preparation of nervonic acid and panax notoginseng total saponins and preparation method of compound preparation
06/19/2013CN103156876A Medicine composition for treating central nervous system diseases and preparation method and application thereof
1 ... 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 ... 1833